Results

Total Results: 1,265 records

Showing results for "hepatitis c".
Users also searched for: hepatitis c

  1. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-fullreport.pdf
    June 01, 2018 - Measure Number 0232 1.C. … c. Care Setting – other – please specify: No. d. … data abstracted for this study did not include indicators of special health care needs. 18 7.C. … in Michigan; medical records were abstracted using the EHR system at each participating site. 11.C. … Electronically display all the information for a test report specified at 42 CFR 26 493.1291(c)
  2. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-fullreport.pdf
    April 02, 2018 - Measure Number 0230 1.C. … c. Care Setting – other – please specify: Yes; emergency department. d. … records data abstracted for this study did not include indicators of special health care needs. 7.C. … Medical records were abstracted using the EHR system at each participating site. 11.C. … Electronically display all the information for a test report specified at 42 CFR 493.1291(c)(1) through
  3. www.ahrq.gov/policymakers/chipra/overview/background/appendix-a8.html
    December 01, 2009 - Format and conduct of consensus development conferences: a multi-nation comparison, in Goodman C and
  4. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/prevention-of-opioid-user-disorder-ehc-tech-brief.pdf
    May 14, 2021 - health consequences, including localized and systemic infections (e.g., cellulitis, endocarditis, HIV, hepatitisc. … Singh S, Clarke C, Lawendy A, et al. … McCracken LM, Boichat C, Eccleston C. … Barber C, Gagnon D, Fonda J, et al.
  5. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - The delivery system (which is also being evaluated for delivering drugs for hepatitis and weight loss … c=101911&p=irol- newsArticle&ID=1653756. 47. … c=101911&p=irol-newsArticle&ID=1653756 http://phx.corporate-ir.net/phoenix.zhtml? … Yang B, D'Vaz R, Negulescu C, et al. … Phend C. ADA: anti-VEGF 'impressive' in sharpening vision. [internet].
  6. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2003_SummaryStats_10PCT_SEVERITY_A.PDF
    January 01, 2003 - : D&C,CONIZATION&RADIO-IMPLNT,MALIG W MCC <= 10 **.** 3640: D&C,CONIZATION EXC FOR MALIGNANCY W/O CC … 120 0.02 3641: D&C,CONIZATION EXC FOR MALIGNANCY W CC 57 0.01 3642: D&C,CONIZATION EXC FOR MALIGNANCY … /OR D&C W MCC <= 10 **.** 3750: VAG DEL W O.R EX STERIL &/OR D&C W/O CC 38 0.00 3751: VAG DEL W O.R … W/O CC 315 0.04 3801: ABORTION W/O D&C W CC 76 0.01 3802: ABORTION W/O D&C W MCC <= 10 **.** 3810: … ABORTN W D&C,ASP CURETT,HYSTEROT W/O CC 476 0.06 3811: ABORTN W D&C,ASP CURETT,HYSTEROT W CC 120 0.02
  7. www.ahrq.gov/research/findings/final-reports/ptfamilyscan/ptfamily3.html
    July 01, 2018 - Appendix A: Draft Key Informant Interview Protocol Appendix B: Summary of Search Terms Appendix C: … medical errors." 24 Likewise, during cognitive testing of AHRQ's Five Steps to Safer Health Care , cc. Five Steps to Safer Health Care.
  8. www.ahrq.gov/research/findings/final-reports/ptflow/section2.html
    July 01, 2018 - Successfully Used by Hospitals to Improve Patient Flow Appendix B: Implementation Plan Template Appendix C:
  9. www.ahrq.gov/patient-safety/quality-resources/tools/chtoolbx/measures/measure-6.html
    November 01, 2017 - Bethell, C, Reuland CH, Halfon N, Schor E.
  10. hcup-us.ahrq.gov/db/nation/kid/tools/stats/PublicSummaryStats_KID_2006_Severity.PDF
    January 01, 2006 - 1227 0.04 542: Vag del w cmp proc ex ster/D&C 5268 0.17 544: D&C, asp curet, hysterot-OB 2797 0.09 … *.** 3640: D&C,CONIZATION EXC FOR MALIGNANCY WO CC 83 0.00 3641: D&C,CONIZATION EXC FOR MALIGNANCY … &/OR D&C W MCC 15 0.00 3750: VAG DEL W O.R EX STERIL &/OR D&C WO CC 89 0.00 3751: VAG DEL W O.R EX … STERIL &/OR D&C W CC 71 0.00 3752: VAG DEL W O.R EX STERIL &/OR D&C W MCC <= 10 **.** 3760: POSTPART … W D&C,ASP CURETT,HYSTEROT WO CC 1823 0.06 3811: ABORTN W D&C,ASP CURETT,HYSTEROT W CC 480 0.02 3812
  11. hcup-us.ahrq.gov/tech_assist/data_query/Methods_Community_Statistics20230207.pdf
    December 01, 2022 - u=https-3A__claritas360.claritas.com_mybestsegments_&d=DwMFAg&c=jf_iaSHvJObTbx-siA1ZOg&r=2qQwVBn6hVQgR7RNjEA4Tc2Yt-lUl674IM-sBUsuioI … 535.30 Alcohol Alcoholic gastritis, with hemorrhage 535.31 Alcohol Fatty liver 571.0 Alcohol Alcohol hepatitis
  12. www.ahrq.gov/research/findings/final-reports/stpra/stpraapd2.html
    April 01, 2018 - Database Analysis Appendix C. Site Visit Protocol Appendix D. … Use betadine for C-section etc if not enough time to dry.
  13. www.ahrq.gov/research/findings/final-reports/stpra/stpra4.html
    April 01, 2018 - Database Analysis Appendix C. Site Visit Protocol Appendix D.
  14. www.uspreventiveservicestaskforce.org/home/getfilebytoken/hbSopN6uA9u-4EQuKtRGDP
    October 01, 2011 - Egger M, Davey Smith G, Schneider M, Minder C. … Jeffery RW, Wing RR, Thorson C, Burton LR, Raether C, Harvey J, et al. … Berne C; Orlistat Swedish Type 2 diabetes Study Group. … Hauptman J, Lucas C, Boldrin MN, Collins H, Segal KR. … Kirk EP, Jacobsen DJ, Gibson C, Hill JO, Donnelly JE.
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
    September 01, 2014 - c. With non sex-specific etiologies 1 d. … c. With non sex-specific etiologies? d. … White C, Ip S, McPheeters M, et al. … C-2 Appendix D. Inclusion Criteria Table D1. … Not SR Getliffe K, Fader M, Allen C, et al.
  16. cds.ahrq.gov/sites/default/files/cds/artifact/476/CDSConnectPilotFinalReport508gel10012018.pdf
    September 01, 2018 - Suggested Citation Meadows G, Moesel C, Sebastian S, et al. … Consultation on the Pain Management Summary CDS and its placement into the clinical workflow c. … c.,,tloM • Non.Opioid M-ldlc.it1t,n5 Pcmazocloo SO MG Oral Tablet Statement 2018-Mor-15 • Nol"I-Ph … Risk Considerallons (7) C) e Mo!>t R.Pt.11nt MME • Urine D11J9 S-c:r.•na O Bcn.zodl.'
  17. digital.ahrq.gov/sites/default/files/docs/citation/cds-connect-pilot-final-report.pdf
    September 01, 2018 - Suggested Citation Meadows G, Moesel C, Sebastian S, et al. … Consultation on the Pain Management Summary CDS and its placement into the clinical workflow c. … c.,,tloM • Non.Opioid M-ldlc.it1t,n5 Pcmazocloo SO MG Oral Tablet Statement 2018-Mor-15 • Nol"I-Ph … Risk Considerallons (7) C) e Mo!>t R.Pt.11nt MME • Urine D11J9 S-c:r.•na O Bcn.zodl.'
  18. meps.ahrq.gov/data_files/publications/mr3/mr3.pdf
    September 01, 1998 - TYPE NAME RH HS PM BQ IN CR ELAINE BRAZIL C RDY C RDY RDY CR JACKIE CALDRON C RDY C RDY RDY CR DONALD … FREUD C RDY C RDY RDY CR PEGGY LACEY C RDY C RDY RDY SAMPLED ADMISSION DATE: 09/11/93 AVAILABLE RESULT … Bethel J, Flyer P, Wolters C. … Tourangeau K, Vincent C, Anderson S, et al. … X X X X Sexually transmitted diseases X X Tuberculosis X X X Urinary tract infection X X X X Viral hepatitis
  19. www.uspreventiveservicestaskforce.org/home/getfilebytoken/Wezro6zTSfAWxCrneF-nxB
    May 01, 2005 - The risk factors examined included age less than 20 years, marital status, history of STD or hepatitis … Sloan NL, Winikoff B, Haberland N, Coggins C, Elias C. … Banikarim C, Chacko MR, Wiemann CM, Smith PB. … Todd CS, Haase C, Stoner BP. … Gift T, Walsh C, Haddix A, Irwin KL.
  20. www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-145-materials-v-a.pdf
    June 25, 2014 - c. … is increased too rapidly; de­ crease in appetite; increase in suicidal thoughts (less common); and hepatitis … Chan E, Zhan C, Homer CJ. … Homer C, Klatka K, Romm D, et al. … D D C C D * Evidence classification/rating scheme described at end of this document Page 2

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive